86 related articles for article (PubMed ID: 29053012)
1. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer.
Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
Biomark Med; 2017 Dec; 11(12):1103-1111. PubMed ID: 29053012
[TBL] [Abstract][Full Text] [Related]
2. The level of S-glutathionylated protein is a predictor for metastasis in colorectal cancer and correlated with those of Nrf2/Keap1 pathway.
Chang LC; Fan CW; Tseng WK; Hua CC
Biomarkers; 2021 Dec; 26(8):780-787. PubMed ID: 34704878
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury.
Yang C; Liu X; Yang F; Zhang W; Chen Z; Yan D; You Q; Wu X
In Vitro Cell Dev Biol Anim; 2017 Mar; 53(3):248-257. PubMed ID: 27815660
[TBL] [Abstract][Full Text] [Related]
4. Associations between the Nrf2/Keap1 pathway and mitochondrial functions in colorectal cancer are affected by metastasis.
Chang LC; Fan CW; Tseng WK; Hua CC
Cancer Biomark; 2020; 27(2):163-171. PubMed ID: 31796664
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis.
Niture SK; Jaiswal AK
J Biol Chem; 2011 Dec; 286(52):44542-56. PubMed ID: 22072718
[TBL] [Abstract][Full Text] [Related]
6. KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells.
Xu Y; Fang F; Miriyala S; Crooks PA; Oberley TD; Chaiswing L; Noel T; Holley AK; Zhao Y; Kiningham KK; Clair DK; Clair WH
Cancer Res; 2013 Jul; 73(14):4406-17. PubMed ID: 23674500
[TBL] [Abstract][Full Text] [Related]
7. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
[TBL] [Abstract][Full Text] [Related]
8. A PGAM5-KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking.
O'Mealey GB; Plafker KS; Berry WL; Janknecht R; Chan JY; Plafker SM
J Cell Sci; 2017 Oct; 130(20):3467-3480. PubMed ID: 28839075
[TBL] [Abstract][Full Text] [Related]
9. The Ratio of Hmox1/Nrf2 mRNA Level in the Tumor Tissue Is a Predictor of Distant Metastasis in Colorectal Cancer.
Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
Dis Markers; 2016; 2016():8143465. PubMed ID: 27999449
[TBL] [Abstract][Full Text] [Related]
10. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.
Cheng J; Qian D; Ding X; Song T; Cai M; Dan Xie ; Wang Y; Zhao J; Liu Z; Wu Z; Pang Q; Zhu L; Wang P; Hao X; Yuan Z
Cell Death Dis; 2018 Sep; 9(10):991. PubMed ID: 30250224
[TBL] [Abstract][Full Text] [Related]
11. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex.
Lo SC; Hannink M
J Biol Chem; 2006 Dec; 281(49):37893-903. PubMed ID: 17046835
[TBL] [Abstract][Full Text] [Related]
12. The tumour/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: a correlation study between the Nrf2 and KRas pathways.
Chang LC; Fan CW; Tseng WK; Chen JR; Hua CC
Biomarkers; 2022 Nov; 27(7):701-707. PubMed ID: 35830714
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
[TBL] [Abstract][Full Text] [Related]
14. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria.
Lo SC; Hannink M
Exp Cell Res; 2008 May; 314(8):1789-803. PubMed ID: 18387606
[TBL] [Abstract][Full Text] [Related]
15. Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate.
Ma K; Zhang Z; Chang R; Cheng H; Mu C; Zhao T; Chen L; Zhang C; Luo Q; Lin J; Zhu Y; Chen Q
Cell Death Differ; 2020 Mar; 27(3):1036-1051. PubMed ID: 31367011
[TBL] [Abstract][Full Text] [Related]
16. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
17. Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL.
Tian H; Zhang B; Di J; Jiang G; Chen F; Li H; Li L; Pei D; Zheng J
Cancer Lett; 2012 Dec; 325(1):26-34. PubMed ID: 22743616
[TBL] [Abstract][Full Text] [Related]
18. Auriculasin enhances ROS generation to regulate colorectal cancer cell apoptosis, ferroptosis, oxeiptosis, invasion and colony formation.
Wang CX; Chen LH; Zhuang HB; Shi ZS; Chen ZC; Pan JP; Hong ZS
Biochem Biophys Res Commun; 2022 Jan; 587():99-106. PubMed ID: 34872005
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex.
Wang YS; Yu P; Wang Y; Zhang J; Hang W; Yin ZX; Liu G; Chen J; Werle KD; Quan CS; Gao H; Zeng Q; Cui R; Liang J; Ding Q; Li YL; Xu ZX
Int J Cardiol; 2018 May; 259():153-162. PubMed ID: 29579593
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue.
Yang SB; Chen X; Wu BY; Wang MW; Cai CH; Cho DB; Chong J; Li P; Tang SG; Yang PC
Scand J Gastroenterol; 2009; 44(12):1443-51. PubMed ID: 19883274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
